We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

175 hedge funds and large institutions have $677M invested in Travere Therapeutics in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 64 increasing their positions, 48 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 21

33% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 48

6% more funds holding

Funds holding: 165 → 175 (+10)

4.07% less ownership

Funds ownership: 119.41% → 115.35% (-4.1%)

16% less capital invested

Capital invested by funds: $807M → $677M (-$129M)

81% less call options, than puts

Call options by funds: $1.09M | Put options by funds: $5.82M

Holders
175
Holders Change
+10
Holders Change %
+6.06%
% of All Funds
2.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
64
Reduced
48
Closed
21
Calls
$1.09M
Puts
$5.82M
Net Calls
-$4.73M
Net Calls Change
+$1.55M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$10.6M
2
EP
Eversept Partners
New York
+$8.06M
3
Millennium Management
Millennium Management
New York
+$7.65M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$7.36M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$6.33M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$40M
2
FCM
Farallon Capital Management
California
-$9.84M
3
APM
Avidity Partners Management
Texas
-$7.43M
4
Goldman Sachs
Goldman Sachs
New York
-$6.51M
5
WP
Woodline Partners
California
-$5.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
76
AllianceBernstein
Tennessee
$544K – – –
ADIM
77
Alpha DNA Investment Management
Maryland
$542K +$593K +70,323 New
ORI
78
Oak Ridge Investments
Illinois
$508K +$65.3K +7,744 +13%
Prudential Financial
79
Prudential Financial
New Jersey
$503K -$201K -23,800 -27%
JFG
80
Jefferies Financial Group
New York
$457K +$500K +59,300 New
GCP
81
GSA Capital Partners
United Kingdom
$452K +$494K +58,601 New
Dimensional Fund Advisors
82
Dimensional Fund Advisors
Texas
$437K +$5.92K +702 +1%
State Board of Administration of Florida Retirement System
83
State Board of Administration of Florida Retirement System
Florida
$433K -$13.1K -1,550 -7%
Wellington Management Group
84
Wellington Management Group
Massachusetts
$428K -$729K -86,424 -61%
AA
85
ALPS Advisors
Colorado
$414K +$55.8K +6,617 +14%
HSBC Holdings
86
HSBC Holdings
United Kingdom
$412K +$32.4K +3,836 +8%
BHCM
87
Brevan Howard Capital Management
Jersey
$375K +$216K +25,553 +111%
Acadian Asset Management
88
Acadian Asset Management
Massachusetts
$368K +$404K +47,881 New
AQR Capital Management
89
AQR Capital Management
Connecticut
$367K +$256K +30,401 +177%
RA
90
Royce & Associates
New York
$367K +$50K +5,932 +14%
NYLIM
91
New York Life Investment Management
New York
$363K +$269K +31,913 +210%
VEA
92
Virtus ETF Advisers
New York
$340K +$53.6K +6,352 +17%
Fisher Asset Management
93
Fisher Asset Management
Washington
$333K – – –
HWAM
94
Hennion & Walsh Asset Management
New Jersey
$314K +$43.2K +5,123 +14%
Capstone Investment Advisors
95
Capstone Investment Advisors
New York
$289K +$157K +18,658 +99%
Tudor Investment Corp
96
Tudor Investment Corp
Connecticut
$288K +$315K +37,386 New
AIG
97
American International Group
New York
$277K -$2.6K -308 -0.9%
Wells Fargo
98
Wells Fargo
California
$263K +$13.9K +1,649 +5%
Invesco
99
Invesco
Georgia
$256K -$184K -21,800 -40%
MIM
100
MetLife Investment Management
New Jersey
$254K -$46K -5,449 -14%
2 3
4
5 6

TVTX Hedge Fund Activity: Q1 2024 in Review

175 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q1 2024, worth a combined $677M — down 16% from $807M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TVTX positions and 21 closed out — a net gain of 10 holders — while 64 added to existing stakes and 48 trimmed.

The largest buyer was State Street, adding an estimated $10.6M. The largest seller was Morgan Stanley, cutting an estimated $40M.

  • 175 institutional investors held Travere Therapeutics (TVTX) as of Q1 2024, up from 165 in Q4 2023.
  • Funds reported $677M of Travere Therapeutics stock for Q1 2024, down 16% quarter-over-quarter.
  • 31 funds opened new Travere Therapeutics positions in Q1 2024 and 21 closed out, a net change of +10 holders.
  • The largest Travere Therapeutics buyer in Q1 2024 was State Street, an estimated $10.6M added.
  • The largest Travere Therapeutics seller in Q1 2024 was Morgan Stanley, an estimated $40M sold.

Based on aggregated 13F filings for Q1 2024.